Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does XANTOFYL Cause Activated partial thromboplastin time prolonged? 43 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Activated partial thromboplastin time prolonged have been filed in association with XANTOFYL. This represents 7.6% of all adverse event reports for XANTOFYL.

43
Reports of Activated partial thromboplastin time prolonged with XANTOFYL
7.6%
of all XANTOFYL reports
43
Deaths
40
Hospitalizations

How Dangerous Is Activated partial thromboplastin time prolonged From XANTOFYL?

Of the 43 reports, 43 (100.0%) resulted in death, 40 (93.0%) required hospitalization, and 40 (93.0%) were considered life-threatening.

Is Activated partial thromboplastin time prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for XANTOFYL. However, 43 reports have been filed with the FAERS database.

What Other Side Effects Does XANTOFYL Cause?

Drug ineffective (446) Macular degeneration (400) Nausea (273) Off label use (272) Abdominal pain (228) Constipation (228) Anaemia (197) Pyrexia (178) Pain (177) Therapeutic product effect incomplete (166)

What Other Drugs Cause Activated partial thromboplastin time prolonged?

DABIGATRAN ETEXILATE (264) HEPARIN (225) RIVAROXABAN (163) WARFARIN (146) ACETAMINOPHEN (119) ALLOPURINOL (110) AMIODARONE (99) METRONIDAZOLE (98) SIMVASTATIN (94) DARBEPOETIN ALFA (93)

Which XANTOFYL Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?

XANTOFYL vs XARELTO XANTOFYL vs XELJANZ XANTOFYL vs XELODA XANTOFYL vs XENAZINE XANTOFYL vs XEPLION

Related Pages

XANTOFYL Full Profile All Activated partial thromboplastin time prolonged Reports All Drugs Causing Activated partial thromboplastin time prolonged XANTOFYL Demographics